Opinion
Anticipating the $1,000 genome
-
Correspondence: Elaine R Mardis emardis@wustl.edu
Genome Sequencing Center, Washington University School of Medicine, 4444 Forest Park Boulevard, St. Louis, MO 63108, USA
Genome Biology 2006, 7:112 doi:10.1186/gb-2006-7-7-112
Published: 27 July 2006Abstract
A new generation of DNA-sequencing platforms will become commercially available over the next few years. These instruments will enable re-sequencing of human genomes at a previously unimagined throughput and low cost. Here, I examine why the $1,000 human genome is an important goal for research and clinical diagnostics, and what will be required to achieve it.